Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre‐François Laterre, Anne-Aurore Duchambon, Peter Pickkers et al.|Intensive Care Medicine|2021Cited by 92
Extracorporeal membrane oxygenation for refractory COVID-19 acute respiratory distress syndromeCamille Le Breton, Damien Roux, Pierre Antoine Billiet et al.|Journal of Critical Care|2020Cited by 32